205 related articles for article (PubMed ID: 27699491)
1. Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten.
Feriotto G; Calza R; Bergamini CM; Griffin M; Wang Z; Beninati S; Ferretti V; Marzola E; Guerrini R; Pagnoni A; Cavazzini A; Casciano F; Mischiati C
Amino Acids; 2017 Mar; 49(3):551-565. PubMed ID: 27699491
[TBL] [Abstract][Full Text] [Related]
2. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
3. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
6. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
7. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.
Rauhavirta T; Oittinen M; Kivistö R; Männistö PT; Garcia-Horsman JA; Wang Z; Griffin M; Mäki M; Kaukinen K; Lindfors K
J Clin Immunol; 2013 Jan; 33(1):134-42. PubMed ID: 22878839
[TBL] [Abstract][Full Text] [Related]
8. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.
Qiao SW; Piper J; Haraldsen G; Oynebråten I; Fleckenstein B; Molberg O; Khosla C; Sollid LM
J Immunol; 2005 Feb; 174(3):1657-63. PubMed ID: 15661929
[TBL] [Abstract][Full Text] [Related]
10. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
[TBL] [Abstract][Full Text] [Related]
11. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
[TBL] [Abstract][Full Text] [Related]
12. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl
Engstrom N; Saenz-Méndez P; Scheers J; Scheers N
Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.
Jang TH; Lee DS; Choi K; Jeong EM; Kim IG; Kim YW; Chun JN; Jeon JH; Park HH
PLoS One; 2014; 9(9):e107005. PubMed ID: 25192068
[TBL] [Abstract][Full Text] [Related]
14. Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with α2-gliadin or gluten.
Engström N; Sandberg AS; Scheers N
Nutrients; 2015 Mar; 7(4):2134-44. PubMed ID: 25816160
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Rauhavirta T; Hietikko M; Salmi T; Lindfors K
Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
[TBL] [Abstract][Full Text] [Related]
16. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.
Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 undergoes a large conformational change upon activation.
Pinkas DM; Strop P; Brunger AT; Khosla C
PLoS Biol; 2007 Dec; 5(12):e327. PubMed ID: 18092889
[TBL] [Abstract][Full Text] [Related]
18. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
19. Competitive Binding of Magnesium to Calcium Binding Sites Reciprocally Regulates Transamidase and GTP Hydrolysis Activity of Transglutaminase 2.
Jeong EM; Lee KB; Kim GE; Kim CM; Lee JH; Kim HJ; Shin JW; Kwon MA; Park HH; Kim IG
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991788
[TBL] [Abstract][Full Text] [Related]
20. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
